Portola Pharma (PTLA) Tops Q1 EPS by 14c

Portola Pharma (NASDAQ: PTLA) reported Q1 EPS of ($0.95), $0.14 better than the analyst estimate of ($1.09). Revenue for the quarter came in at $2.36 million versus the consensus estimate of $2.6 million.

For earnings history and earnings-related data on Portola Pharma (PTLA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BMO starts chip stocks coverage: Here are its preferred picks
• Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results